Get the Stockscreener App
1.16
0.00%
0.00
After Hours:
1.15
-0.01
-0.86%
Sunshine Biopharma Inc stock is traded at $1.16, with a volume of 98,725.
It is up +0.00% in the last 24 hours and down -33.71% over the past month.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
See More
Previous Close:
$1.16
Open:
$1.15
24h Volume:
98,725
Relative Volume:
0.09
Market Cap:
$4.50M
Revenue:
$35.49M
Net Income/Loss:
$-6.04M
P/E Ratio:
-0.0891
EPS:
-13.0191
Net Cash Flow:
$-6.42M
1W Performance:
+0.87%
1M Performance:
-33.71%
6M Performance:
-90.17%
1Y Performance:
-91.83%
1-Day Range:
$1.14
$1.17
1-Week Range:
$1.03
$1.23
52-Week Range:
$1.03
$24.30
Sunshine Biopharma Inc Stock (SBFM) Company Profile
Name
Sunshine Biopharma Inc
Sector
Phone
954-330-0684
Address
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SBFM
Sunshine Biopharma Inc
|
1.16 | 4.50M | 35.49M | -6.04M | -6.42M | -13.02 |
TAK
Takeda Pharmaceutical Co Adr
|
18.18 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
10.00 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
37.34 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.73 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
513.12 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc Stock (SBFM) Latest News
Sunshine Biopharma wins Canadian approval for generic Enalapril tablets - Bitget
SBFM Looks 55.2% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus
BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril - Bitget
Sunshine Biopharma receives Canadian approval for generic enalapril - Investing.com
Sunshine Biopharma Receives Canadian Regulatory Approval for Enalapril, Expanding Into $25.94 Billion Global Anti-Hypertensive Drug Market - Eagle-Tribune
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug - Yahoo Finance
Sunshine (SBFM) Quarterly Performance Check: The Company Lists Its Latest Available Figures in the Reported Period; Session Reaction: The Stock Ends Up 1.79% in the Latest ReadingEarnings Momentum Score - vinanet.vn
101,973 Common Stock of Sunshine Biopharma, Inc. are subject to a Lock-Up Agreement Ending on 18-AUG-2026. - marketscreener.com
Sunshine Biopharma earnings beat by $0.05, revenue topped estimates - Investing.com
SBFM Q1 2026 Earnings: Clinical-Stage Biotech Posts $0.25 Per-Share Loss as Shares Slip 4.17%Revenue Warning Signal - vinanet.vn
SBFM Q1 2026 Earnings: Reported Loss of $0.25 Per Share as Stock Declines 4.17%Pre-Earnings Setup - Vinanet
SBFM Q1 2026 Earnings: Net Loss of -$0.25 Per Share as Pre-Revenue Oncology Developer Presses OnForward Guidance Trends - vinanet.vn
L1 Capital (SBFM) discloses 4.99% Sunshine Biopharma stake plus large warrant position - Stock Titan
Sunshine Biopharma Inc (NASDAQ: SBFM) Share Price, SBFM Stock News, SBFM Share Price & Updates - kalkine.ca
Sunshine Biopharma (SBFM) investors cap warrant-driven stake at 9.99% - Stock Titan
Sunshine Biopharma (SBFM) Earnings Date and Reports 2026 - MarketBeat
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market - The Lawton Constitution
Sunshine Biopharma (SBFM) Holds Gains at $1.23 as Stock Stays Rangebound Between Key LevelsActive ETF Flow - dars.gov.et
SBFM Stock Holds Support As Traders Eye Next Move - timothysykes.com
SBFM Stock Holds Support As Sunshine Biopharma Tightens Cash Control - StocksToTrade
SBFM Stock Holds Range As Traders Weigh Weak Margins - timothysykes.com
SBFM Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTrade
SBFM Stock Pops As Health Canada Greenlights New Generics - StocksToTrade
Amoxicillin Market Estimated at $4.9B as Canada Shipments Begin - Stock Titan
Sunshine Biopharma Inc. Revenue Breakdown – NASDAQ:SBFMW - TradingView
SBFM Looks 84.2% Undervalued on GF Value™ Despite Distressed Fun - GuruFocus
Sunshine Biopharma receives Canadian approval for generic dienogest By Investing.com - Investing.com Nigeria
Sunshine Biopharma receives Canadian approval for generic dienogest - Investing.com
Sunshine Biopharma's 2mg Tablet for Endometriosis Pain Wins Canadian Approval - Stock Titan
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval - Benzinga
SBFM Q2'26 Earnings: EPS estimate is (1.20) USD - TradingView
Sunshine Biopharma wins Canadian approval for generic Dienogest tablets - Bitget
Sunshine Biopharma cuts exercise price of outstanding Series B warrants to $1.22 - Bitget
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Loss Per Share Widens as Revenue Remains ZeroPeak Earnings Alert - dars.gov.et
SBFM Looks 79.1% Undervalued on GF Value™ Amid Challenging Finan - GuruFocus
Sunshine Biopharma receives Canadian approval for ondansetron - Investing.com
Sunshine Biopharma receives Canadian approval for ondansetron By Investing.com - Investing.com Canada
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting - New Castle News
Sunshine Biopharma adds oral disintegrating tablets for chemotherapy nausea - Stock Titan
Sunshine Biopharma Inc (SBFM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SBFM|Sunshine Biopharma Inc|Price:1.696| - TradingKey
Sunshine Biopharma Inc (SBFM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SBFM|Sunshine Biopharma Inc|Price:1.230|Chg%:-0.170 - TradingKey
SBFM Q1 2026 Earnings: Net Loss Widens as Pre-Revenue Biotech Focuses on R&D Pipeline - vinanet.vn
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Continued R&D Investment Drives Net Loss, No Revenue ReportedEarnings Outlook Update - dars.gov.et
Sunshine Biopharma Inc. Revenue Breakdown – NASDAQ:SBFM - TradingView
Sunshine Biopharma Inc. Revenue Breakdown – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc (SBFM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Continued R&D Investment Leads to Net Loss Amid No Revenue - dars.gov.et
Price to sales forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
SBFM Q1 2026 Earnings: Net Loss Per Share of $0.25 as Pre-Revenue Biopharma Advances PipelineGuidance Update - vinanet.vn
Sunshine Biopharma Inc Stock (SBFM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):